For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Product Information
Phase Detail
Biozen Intact XB-C8<br class="t-last-br" />
Biozen Intact XB-C8 core-shell UHPLC columns provide extremely for impurity profiling and characterization of intact biologic fragments

Biozen Intact XB-C8

Impurity profiling and characterization of intact biologic fragments is a challenging undertaking because of the need to identify very small differences between variants. Both bioZen Intact columns contain skillfully manufactured large pore core-shell particles that provide narrower, taller peaks in conjunction with higher resolution between the target HC/LC, Fc/Fab, or isoforms.

Particle Size
3.6
Recommended Use
Fast separation of intact and subunit separation with hydrophobic selectivity

Minimize your priming with our BioTi™ Biocompatible hardware

Application ID 24717

Columns:
Dimension:
150 x 4.6 mm
Mobile Phase:
50 mM Dipotassium Phosphate + 100 mM Sodium Sulfate, pH 5.0
Flow Rate:
0.3 mL/min
Temperature:
Ambient
Detection:
UV @ 280 nm
Sample:
1. γ-Globulin, 5 mg/mL
2. Ovalbumin, 1 mg/mL

Intact and Fragment Analysis

Impurity profiling and characterization of intact biologic fragments is a challenging undertaking because of the need to identify very small differences between variants. Both bioZen Intact columns contain skillfully manufactured large pore core-shell particles that provide narrower, taller peaks in conjunction with higher resolution between the target HC/LC, Fc/Fab, or isoforms.

Intact Trastuzumab at 70, 80, and 90°C

Column:
bioZen 3.6 µm Intact XB-C8
Dimension:
00F-4766-AN
Part No.:
150 x 2.1 mm
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
Time (min)
0
1
13
 
% B
20
20
45
Flow Rate:
0.5 mL/min
Temperature:
70 °C
 80 °C
90 °C
Detection:
UV @ 280 nm
Sample:
1. Trastuzumab

Infliximab F(ab)2

Column:
bioZen 3.6 µm Intact XB-C8
Dimension:
150 x 2.1 mm
Part No.:
00F-4766-AN
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
Time (min)
0
1
13
 
% B
20
20
60
Flow Rate:
0.5 mL/min
Temperature:
80 °C
Detection:
UV @ 280 nm
Sample:
1. Infliximab F(ab)2

Cetuximab

Column:
bioZen 3.6 µm Intact XB-C8
Dimension:
150 x 2.1  mm
Part No.:
00F-4766-AN
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
Time (min)
0
1
13
 
% B
20
20
45
Flow Rate:
0.5 mL/min
Temperature:
80 °C
Detection:
UV @ 280 nm
Sample:
1. Cetuximab

Drug Antibody Ratio (DAR)

With a direct effect on efficacy and safety, conjugation for each ADC must be well understood. The bioZen Intact XB-C8 provides an excellent vehicle for determining drug load distribution and DAR for ADCs. Its large pore size allows intact ADCs to interact with a moderately retentive stationary phase while the core-shell particle supplies increased efficiency to deliver the required resolution between ADC species with differing drug loads.

Herceptin—vcMMAE using bioZen 3.6 µm Intact XB-C8

 

Herceptin—mcMMAF using bioZen 3.6 µm Intact XB-C8

scFc and F(ab’)2

Our bioZen Intact XB-C8 column shows improved peak shape and scFc detection.

Comparative separations may not be representative of all applications.
Conditions for all columns:

Columns:
bioZen 3.6 μm Intact XB-C8
Agilent 3.5 μm AdvanceBio RP-mAb SB-C8
Dimension:
150 x 2.1  mm
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
20-45 %  B in 12 minutes
Flow Rate:
0.5 mL/min
Temperature:
80 °C
Detection:
UV @ 280 nm
Injection Volume:
1 µL
Sample:
Cetuximab

Heavy Chain, Light Chain Analysis

Observe excellent separation of heavy chain variants using the bioZen™ Intact XB-C8 column in your mAb intact fragment analysis.

Conditions for all columns:

Columns:
bioZen 3.6 μm Intact XB-C8
Agilent 3.5 μm AdvanceBio RP-mAb SB-C8
Dimension:
150 x 2.1  mm
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
20-45 %  B in 12 minutes
Flow Rate:
0.5 mL/min
Temperature:
80 °C
Detection:
UV @ 280 nm
Injection Volume:
1 µL
Sample:
Cetuximab

Distilled Alcohol Standard by Neat Injection on GC-FID

Comparative separations may not be representative of all applications.
Conditions for all columns:

Columns:
bioZen 3.6 μm Intact XB-C8
Agilent 3.5 μm AdvanceBio RP-mAb SB-C8
Dimension:
150 x 2.1  mm
Mobile Phase:
A: 0.1 % TFA in Water
B: 0.1 % TFA in Acetonitrile
Gradient:
20-45 %  B in 12 minutes
Flow Rate:
0.5 mL/min
Temperature:
80 °C
Detection:
UV @ 280 nm
Injection Volume:
1 µL
Sample:
1. Rituximab